Back to Search
Start Over
Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO(r)) in Women with ER+|HER2- Breast Cancer
- Source :
- Plus Company Updates. July 1, 2024
- Publication Year :
- 2024
-
Abstract
- SEATTLE: Atossa Therapeutics, Inc. has issued the following news release: Atossa Therapeutics, Inc. (Nasdaq: ATOS) ('Atossa' or the 'Company') today announced protocol changes in the previously initiated study to evaluate [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.799718600